These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 903037

  • 1. Distribution of plasma phenobarbital, diphenylhydantoin and primidone levels in epileptic patients.
    Watanabe S, Kuyama C, Yokoyama S, Kubo S, Iwai H.
    Folia Psychiatr Neurol Jpn; 1977; 31(2):205-17. PubMed ID: 903037
    [No Abstract] [Full Text] [Related]

  • 2. Serum levels of diphenylhydantoin and phenobarbital in epileptic children receiving diphenylhydantoin, phenobarbital and-or mysoline.
    Yoshida T, Karahashi M, Tanabu M, Takagi T, Arakawa T.
    Tohoku J Exp Med; 1974 Feb; 112(2):169-75. PubMed ID: 4836029
    [No Abstract] [Full Text] [Related]

  • 3. Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.
    Borst SI, Lockwood CH.
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):309-14. PubMed ID: 1242131
    [Abstract] [Full Text] [Related]

  • 4. Primidone, diphenylhydantoin and phenobarbital. Aspects of acute and chronic toxicity.
    Gallagher BB, Baumel IP, Mattson RH, Woodbury SG.
    Neurology; 1973 Feb; 23(2):145-9. PubMed ID: 4734509
    [No Abstract] [Full Text] [Related]

  • 5. In vivo interaction of anticonvulsant drugs. The mathematical correlation of plasma levels of anticonvulsant drugs in epileptic patients.
    Abarbanel J, Herishanu Y, Rosenberg P, Eylath U.
    J Neurol; 1978 May 18; 218(2):137-44. PubMed ID: 78974
    [Abstract] [Full Text] [Related]

  • 6. The necessity of drug level monitoring in anticonvulsant drug therapy.
    Davis HL, Bailey DG, Johnson GE, Wilson TW.
    Can J Physiol Pharmacol; 1976 Dec 18; 54(6):850-8. PubMed ID: 1021220
    [Abstract] [Full Text] [Related]

  • 7. The role of antiepileptic blood levels in the treatment of patients with epilepsy.
    Fincham RW, Schottelius DD.
    J Iowa Med Soc; 1973 Sep 18; 63(9):433-6. PubMed ID: 4742131
    [No Abstract] [Full Text] [Related]

  • 8. Delivery of anticonvulsant drug therapy in epileptic patients assessed by plasma level analyses.
    Wilson JT, Wilkinson GR.
    Neurology; 1974 Jul 18; 24(7):614-23. PubMed ID: 4858085
    [No Abstract] [Full Text] [Related]

  • 9. Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy.
    Farnbach GC.
    J Am Vet Med Assoc; 1984 May 01; 184(9):1117-20. PubMed ID: 6725128
    [Abstract] [Full Text] [Related]

  • 10. Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatography.
    Kupferberg HJ.
    Clin Chim Acta; 1970 Aug 01; 29(2):282-8. PubMed ID: 5493185
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Special viewpoints in the treatment with anticonvulsants in childhood. Value of determination of serum level of anticonvulsants in the treatment of seizures].
    Windorfer A.
    Fortschr Med; 1974 Oct 10; 92(28):1102-4. PubMed ID: 4457423
    [No Abstract] [Full Text] [Related]

  • 13. The effects of phenytoin on phenobarbitone and primidone metabolism.
    Lambie DG, Johnson RH.
    J Neurol Neurosurg Psychiatry; 1981 Feb 10; 44(2):148-51. PubMed ID: 7217971
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Therapeutic and pharmacokinetic effects of increasing phenytoin in chronic epileptics on multiple drug therapy.
    Lambie DG, Johnson RH, Nanda RN, Shakir RA.
    Lancet; 1976 Aug 21; 2(7982):386-9. PubMed ID: 73851
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The influence of diphenylhydantoin on primidone metabolism.
    Fincham RW, Schottelius DD, Sahs AL.
    Arch Neurol; 1974 Mar 21; 30(3):259-62. PubMed ID: 4812960
    [No Abstract] [Full Text] [Related]

  • 18. Disappearance of phenobarbital and diphenylhydantoin from serum of children.
    Garrettson LK, Dayton PG.
    Clin Pharmacol Ther; 1970 Mar 21; 11(5):674-9. PubMed ID: 5455632
    [No Abstract] [Full Text] [Related]

  • 19. Variation in response to anticonvulsants in a group of epileptic patients.
    Travers RD, Gallagher BB, Glaser GH.
    Trans Am Neurol Assoc; 1971 Mar 21; 96():110-2. PubMed ID: 5159062
    [No Abstract] [Full Text] [Related]

  • 20. Elevation of diphenylhydantoin and primidone serum concentration by addition of dipropylacetate, a new anticonvulsant drug.
    Windorfer A, Sauer W, Gädeke R.
    Acta Paediatr Scand; 1975 Sep 21; 64(5):771-2. PubMed ID: 1101639
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.